Furthermore, it inhibits the expressions of TGF-β, Smad2/3, p-Smad2/3, and Smad4 in tumor tissues, suggesting its inhibitive activities on the TGF-β/Smad pathway [42]. Here, SMAD2 is linked to neoplasm.